CN105585605A - Synthetic method for obeticholic acid intermediate - Google Patents

Synthetic method for obeticholic acid intermediate Download PDF

Info

Publication number
CN105585605A
CN105585605A CN201610148290.3A CN201610148290A CN105585605A CN 105585605 A CN105585605 A CN 105585605A CN 201610148290 A CN201610148290 A CN 201610148290A CN 105585605 A CN105585605 A CN 105585605A
Authority
CN
China
Prior art keywords
acid intermediate
synthetic method
cholic acid
shellfish cholic
understand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610148290.3A
Other languages
Chinese (zh)
Inventor
李虹霖
占伟
谢建
赖永新
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chengdu Xingong Biotechnology Co Ltd
Original Assignee
Chengdu Xingong Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chengdu Xingong Biotechnology Co Ltd filed Critical Chengdu Xingong Biotechnology Co Ltd
Priority to CN201610148290.3A priority Critical patent/CN105585605A/en
Publication of CN105585605A publication Critical patent/CN105585605A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Saccharide Compounds (AREA)

Abstract

The invention discloses a synthetic method for an obeticholic acid intermediate. The method includes the steps that organic solvent is poured into a reactor protected by inert gas, 3 alpha-hydroxyl-7-keto-5beta-cholane-24-oate is dissolved into the organic solvent, and then organic alkali is added; the solution is cooled to 0 DEG C-5 DEG C, then carbonate is slowly added dropwise to protect the 3-position hydroxyl group, after dropwise addition is completed, the reaction solution is heated to 20 DEG C-50 DEG C and is stirred for 2-8 h, and then the organic solvent is removed through decompression concentration; ice water is added for dissolution, ethyl acetate is added to extract the water phase, organic layers are combined and washed, an appropriate amount of anhydrous sodium sulfate is adopted for drying so that the organic layers are concentrated, and the obeticholic acid intermediate is obtained. The 3-position hydroxyl group is protected with carbonate first, the 7-position carbonyl enol is protected in a trimethylsilylation mode, the dosage of LDA is reduced by a half, and the efficiency of the condensation reaction is higher.

Description

A kind of synthetic method of shellfish cholic acid intermediate difficult to understand
Technical field
Embodiments of the present invention relate to medical technical field, and more specifically, embodiments of the present invention relate toA kind of synthetic method of shellfish cholic acid intermediate difficult to understand.
Background technology
Shellfish cholic acid difficult to understand is a kind of new drug for cholestasis type cirrhosis, and its synthetic route all need to be 7 at presentPosition carbonyl and acetaldehyde condensation, before this, need to protect 3 hydroxyls; Patent US2008/0214515A1 has adopted 3 hydroxyls and 7 methods that the protection of carbonyl enol trimethyl silicone hydride is carried out simultaneously, concreteFlow process is as follows:
But said method need to adopt more than at least two equivalents LDA as alkali, and the volume of reaction is bigger than normal,Efficiency is lower; Therefore develop a kind of LDA consumption few, the effective method of condensation reaction is necessary.
Summary of the invention
The present invention has overcome the deficiencies in the prior art, and a kind of synthetic method of shellfish cholic acid intermediate difficult to understand is provided, withIt is large that expectation can solve in shellfish cholic acid building-up process difficult to understand LDA consumption, the problem that reaction efficiency is low.
For solving above-mentioned technical problem, one embodiment of the present invention by the following technical solutions:
A synthetic method for shellfish cholic acid intermediate difficult to understand, adopts 3 hydroxyls of carbonic ester protection, concrete steps asUnder:
A, first organic solvent is packed in the reactor of inert gas shielding, then by 3 Alpha-hydroxies-7-ketone-5 β-courageAlkane-24-acid methyl esters is dissolved in described organic solvent, adds subsequently organic base;
B, the solution that steps A is obtained are cooled to 0~5 DEG C, then slowly drip 3 hydroxyls of carbonic ester protectionBase, after dripping, is warming up to 20~50 DEG C by reactant liquor and stirs 2~8h, and then reduced pressure concentration is removed organicSolvent;
C, the concentrate obtaining to step B add frozen water that it is dissolved, and then add ethyl acetate to extract water,Merge organic layer, washing organic layer, then adopts appropriate anhydrous sodium sulfate drying, makes organic layer concentrated dry,Obtain described shellfish cholic acid intermediate difficult to understand.
In the synthetic method of above-mentioned shellfish cholic acid intermediate difficult to understand, described organic solvent be ethyl acetate, butyl acetate,Carrene or oxolane.
In the synthetic method of above-mentioned shellfish cholic acid intermediate difficult to understand, described organic base is triethylamine or pyridine.
In the synthetic method of above-mentioned shellfish cholic acid intermediate difficult to understand, described carbonic ester is ethyl chloroformate, chloro-carbonic acid thirdEster or butyl chlorocarbonate.
In the synthetic method of above-mentioned shellfish cholic acid intermediate difficult to understand, described 3 Alpha-hydroxies-7-ketone-5 β-cholane-24-acid methyl estersWith the mass ratio of organic base be 8~9:4.5.
In the synthetic method of above-mentioned shellfish cholic acid intermediate difficult to understand, described 3 Alpha-hydroxies-7-ketone-5 β-cholane-24-acid methyl estersWith the mass ratio of carbonic ester be 8~9:4.
In the synthetic method of above-mentioned shellfish cholic acid intermediate difficult to understand, described washing organic layer refers to uses 10%HCl successivelyThe aqueous solution, saturated sodium bicarbonate solution and saturated nacl aqueous solution washing.
Prepared by the present invention is that shellfish cholic acid intermediate difficult to understand i.e. 3 α-carbonic ester-7-ketone-5 β-cholane-24-acid methyl esters (is changedCompound 2), utilize this intermediate can prepare 3 Alpha-hydroxies-6-ethylidene-7-ketone-5 β-cholane-24-acid methyl esters and (changeCompound 4), idiographic flow is as follows:
The concrete grammar of preparing compound 3 from compound 2 is: by vacuum/nitrogen displacement three times for reaction bulb,Under micro-nitrogen air-flow protection, add shellfish cholic acid intermediate 10.0g difficult to understand that anhydrous tetrahydro furan 80g, the present invention synthesize,Trim,ethylchlorosilane 6.84g, replaces three times by vacuum/nitrogen again. Mixed solution is precooled to-30~-25 DEG C.Keep-30~-25 DEG C to drip 26.0gLDA (2.0M/L). After dripping ,-30~-25 DEG C are stirred 2~3h,Monitoring reacts completely. Add 8.5g triethylamine, stir 30~60min. Be warming up to 0~10 DEG C, drip 80gSaturated sodium bicarbonate solution. Reactant liquor adds respectively 100g, the extraction of 50g ethyl acetate. Merging organic layer dividesYong 100g saturated sodium bicarbonate, 100g water, the washing of 100g saturated nacl aqueous solution. Add anhydrous in right amountDried over sodium sulfate. Be evaporated to dryly, obtain crude product 12.6g.
The concrete grammar of preparing compound 4 from compound 3 is: by vacuum/nitrogen displacement three times for reaction bulb,Be dissolved in anhydrous methylene chloride (30g) by preparing the described crude product 12.6g that compound 3 obtains, then use vacuum/Nitrogen replacement three times. Mixed solution is cooled to-78~-70 DEG C. Keep-78~-70 DEG C and add 1.7g acetaldehyde.Keep-78~-70 DEG C to drip 10.7g BFEE. After dripping, keep-78~-70 DEG C stir 2~3h, monitoring raw material reaction is complete. Rising temperature to 25~30 DEG C, stir 1~2h. Adjustment temperature to 10~20 DEG C, drip 10g saturated sodium bicarbonate solution. Add 50g carrene and 30g water, washing point water outletLayer. Organic layer is respectively with 30g saturated sodium bicarbonate solution and the washing of 30g saturated nacl aqueous solution. Organic layerBe concentrated into dry 10.5g, obtain 4.2g compound 4 through recrystallization.
Compared with prior art, one of beneficial effect of the present invention is: the present invention is first by 3 hydroxyl carbonic estersProtect, then to 7 carbonyl enol trimethyl silicone hydride protections, not only LDA consumption reduces half, meanwhile,The efficiency of condensation reaction is higher.
Detailed description of the invention
In order to make object of the present invention, technical scheme and advantage clearer, below in conjunction with embodiment,The present invention is further elaborated. Should be appreciated that specific embodiment described herein only in order toExplain the present invention, be not intended to limit the present invention.
Embodiment 1:
Ethyl acetate (40g) is packed in the reactor of inert gas shielding, by 3 Alpha-hydroxies-7-ketone-5 β-cholane-24-acid methyl esters (8.47g) is dissolved in wherein, adds 4.5g pyridine. This solution is cooled to 0 DEG C, slowlyDrip ethyl chloroformate (4.0g). After ethyl chloroformate drips, reactant liquor is warming up to 22 DEG C, keeps22 DEG C are stirred 2.5h. Reduced pressure concentration is removed ethyl acetate. Add 34g frozen water to dissolve concentrate, then divideDo not add 17g, 17g, 8.5g ethyl acetate to extract water three times, merge three times organic layer. Organic layerUse respectively the 8.5g10%HCl aqueous solution, 8.5g saturated sodium bicarbonate solution, 8.5g saturated sodium-chloride is moltenLiquid washing, then use appropriate anhydrous sodium sulfate drying, make organic layer concentrated dry, obtain crude product 10.1g, straightConnect the preparation for above-claimed cpd 4, three step total recoverys 46%.
Embodiment 2:
Oxolane (40g) is packed in the reactor of inert gas shielding, by 3 Alpha-hydroxies-7-ketone-5 β-cholane-24-acid methyl esters (8.47g) is dissolved in wherein, adds 4.5g pyridine. This solution is cooled to 5 DEG C, slowlyDrip propyl chlorocarbonate (4.0g). After propyl chlorocarbonate drips, reactant liquor is warming up to 25 DEG C, keeps25 DEG C are stirred 2h. Reduced pressure concentration is removed oxolane. Add 34g frozen water to dissolve. Add respectively 17g,17g, 8.5g ethyl acetate extract water three times, merge three times organic layer. Organic layer is used respectively 8.5g10%The HCl aqueous solution, 8.5g saturated sodium bicarbonate solution, the washing of 8.5g saturated nacl aqueous solution, anhydrous in right amountDried over sodium sulfate. Organic layer is concentrated dry, obtains crude product 10.3g and be directly used in the preparation of above-claimed cpd 4,Three step total recoverys 48%.
Embodiment 3:
Butyl acetate (40g) is packed in the reactor of inert gas shielding, by 3 Alpha-hydroxies-7-ketone-5 β-cholane-24-acid methyl esters (8.47g) is dissolved in wherein, adds 4.5g triethylamine. This solution is cooled to 2 DEG C, slowThe slow butyl chlorocarbonate (4.0g) that drips. After butyl chlorocarbonate drips, reactant liquor is warming up to 20 DEG C, protectsHold 20 DEG C and stir 3h. Reduced pressure concentration is removed butyl acetate. Add 34g frozen water to dissolve. Add respectively 17g,17g, 8.5g ethyl acetate extract water three times, merge three times organic layer. Organic layer is used respectively 8.5g10%The HCl aqueous solution, 8.5g saturated sodium bicarbonate solution, the washing of 8.5g saturated nacl aqueous solution, anhydrous in right amountDried over sodium sulfate. Organic layer is concentrated dry, obtains crude product 10.2g and be directly used in the preparation of above-claimed cpd 4,Three step total recoverys 47%.
Embodiment 4:
Carrene (40g) is packed in the reactor of inert gas shielding, by 3 Alpha-hydroxies-7-ketone-5 β-courageAlkane-24-acid methyl esters (8.47g) is dissolved in wherein, adds 4.5g triethylamine. This solution is cooled to 0 DEG C, slowlyDrip ethyl chloroformate (4.0g). After ethyl chloroformate drips, reactant liquor is warming up to 25 DEG C, keeps 25 DEG CStir 3 hours. Reduced pressure concentration is removed carrene. Add 34g frozen water to dissolve. Add respectively 17g, 17g,8.5g ethyl acetate extracts water three times, merges three times organic layer. Organic layer is used respectively 8.5g10%HCl waterSolution, 8.5g saturated sodium bicarbonate solution, the washing of 8.5g saturated nacl aqueous solution, appropriate anhydrous sodium sulfate is dryDry. Organic layer is concentrated dry, obtains crude product 10.0g and be directly used in the preparation of above-claimed cpd 4, three step total recoverys46%。
Although with reference to explanatory embodiment of the present invention, invention has been described here,, should manageSeparate, those skilled in the art can design a lot of other amendment and embodiments, these amendments and enforcementWithin mode will drop on the disclosed principle scope and spirit of the application. More particularly, disclosed in the applicationIn scope, can carry out multiple modification and improvement to the building block of subject combination layout and/or layout. ExceptThe modification that building block and/or layout are carried out and improve outside, to those skilled in the art, otherPurposes will be also obvious.

Claims (7)

1. a synthetic method for shellfish cholic acid intermediate difficult to understand, is characterized in that adopting 3 hydroxyls of carbonic ester protection,Concrete steps are as follows:
A, first organic solvent is packed in the reactor of inert gas shielding, then by 3 Alpha-hydroxies-7-ketone-5 β-courageAlkane-24-acid methyl esters is dissolved in described organic solvent, adds subsequently organic base;
B, the solution that steps A is obtained are cooled to 0~5 DEG C, then slowly drip 3 hydroxyls of carbonic ester protectionBase, after dripping, is warming up to 20~50 DEG C by reactant liquor and stirs 2~8h, and then reduced pressure concentration is removedOrganic solvent;
C, the concentrate obtaining to step B add frozen water that it is dissolved, and then add ethyl acetate to extract waterPhase, merges organic layer, and washing organic layer, then adopts appropriate anhydrous sodium sulfate drying, makes organic layerConcentrated dry, obtain described shellfish cholic acid intermediate difficult to understand.
2. the synthetic method of shellfish cholic acid intermediate difficult to understand according to claim 1, is characterized in that described organicSolvent is ethyl acetate, butyl acetate, carrene or oxolane.
3. the synthetic method of shellfish cholic acid intermediate difficult to understand according to claim 1, is characterized in that described organicAlkali is triethylamine or pyridine.
4. the synthetic method of shellfish cholic acid intermediate difficult to understand according to claim 1, is characterized in that described carbonic acidEster is ethyl chloroformate, propyl chlorocarbonate or butyl chlorocarbonate.
5. the synthetic method of shellfish cholic acid intermediate difficult to understand according to claim 1, it is characterized in that described 3 α-The mass ratio of hydroxyl-7-ketone-5 β-cholane-24-acid methyl esters and organic base is 8~9:4.5.
6. the synthetic method of shellfish cholic acid intermediate difficult to understand according to claim 1, it is characterized in that described 3 α-The mass ratio of hydroxyl-7-ketone-5 β-cholane-24-acid methyl esters and carbonic ester is 8~9:4.
7. the synthetic method of shellfish cholic acid intermediate difficult to understand according to claim 1, is characterized in that described washingOrganic layer refers to uses the 10%HCl aqueous solution, saturated sodium bicarbonate solution and saturated nacl aqueous solution successivelyWashing.
CN201610148290.3A 2016-03-15 2016-03-15 Synthetic method for obeticholic acid intermediate Pending CN105585605A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610148290.3A CN105585605A (en) 2016-03-15 2016-03-15 Synthetic method for obeticholic acid intermediate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610148290.3A CN105585605A (en) 2016-03-15 2016-03-15 Synthetic method for obeticholic acid intermediate

Publications (1)

Publication Number Publication Date
CN105585605A true CN105585605A (en) 2016-05-18

Family

ID=55925541

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610148290.3A Pending CN105585605A (en) 2016-03-15 2016-03-15 Synthetic method for obeticholic acid intermediate

Country Status (1)

Country Link
CN (1) CN105585605A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115785183A (en) * 2020-04-23 2023-03-14 江西青峰药业有限公司 Preparation method and application of 3 alpha, 7 alpha-dihydroxy-6 alpha-ethyl-5 beta-cholane-24-aldehyde

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101203526A (en) * 2005-05-19 2008-06-18 伊莱吉尔瑞公司 Process for preparing 3alpha(beta)-7alpha(beta)-dihydroxy-6alpha(beta)-alkyl-5beta-cholanic acid
CN104558086A (en) * 2014-12-25 2015-04-29 康美(北京)药物研究院有限公司 Preparation method for 5 beta-3 alpha, 7 alpha-dihydroxy-6 alpha-ethyl-cholanic acid

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101203526A (en) * 2005-05-19 2008-06-18 伊莱吉尔瑞公司 Process for preparing 3alpha(beta)-7alpha(beta)-dihydroxy-6alpha(beta)-alkyl-5beta-cholanic acid
CN104558086A (en) * 2014-12-25 2015-04-29 康美(北京)药物研究院有限公司 Preparation method for 5 beta-3 alpha, 7 alpha-dihydroxy-6 alpha-ethyl-cholanic acid

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
R. PÉREZ GIL ET AL.: "Synthesis of Analogues of Brassinosteroids with 5β-Cholanic Acid Skeleton", 《SYNTHETIC COMMUNICATIONS》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115785183A (en) * 2020-04-23 2023-03-14 江西青峰药业有限公司 Preparation method and application of 3 alpha, 7 alpha-dihydroxy-6 alpha-ethyl-5 beta-cholane-24-aldehyde

Similar Documents

Publication Publication Date Title
CN105130934A (en) Butyl phthalide raw material drug product and preparation method thereof
CN103073536B (en) Preparation method of ilaprazole
CN105585605A (en) Synthetic method for obeticholic acid intermediate
CN109824493A (en) The preparation method of one kind 10,10- dimethyl anthrone
CN107501373B (en) A kind of preparation method of danabol
CN101492455B (en) Optical pure levorotation cephalotaxine and separation purification method
CN106008554A (en) Preparation method and product of ceftriaxone sodium sterile powder
CN108047093A (en) A kind of preparation method of xenyl aminopropan aldehyde compound
CN105085242A (en) Synthetic method of high-quality acetonedicarboxylic acid and acetonedicarboxylate
CN106008384A (en) Refinement method of valsartan
CN104744537A (en) Synthetic method of capecitabine
CN103524360B (en) A kind of synthetic method of S 16257-2 key intermediate
CN102558268A (en) Process for preparing tauroursodeoxycholic acid hydrate
CN107200763A (en) A kind of method using chenodeoxycholic acid as Material synthesis lithocholic acid
CN103755577B (en) A kind of method reclaiming Transbroncho alkali from Ambroxol HCl refinement mother liquor
CN104447472A (en) Synthesis method of D)-2-benzyl-N,N-dimethyl-aziridinyl-1-sulfonamide
CN102351875B (en) Method for recycling mother solution generated in process of producing artemether
CN102260309B (en) Method for preparing high-purity capecitabine
CN101560236B (en) Method for synthesizing marine polyhydroxyl sterol (25R)-5alpha -cholest-3 beta, 5alpha, 6beta, 26-tetrol
CN103351418A (en) Semi-synthesis process of active natural compound betulinic acid
CN105753747B (en) A kind of industrialized production new method for preparing high-purity docusate sodium PEG solution
CN105237606B (en) It is a kind of to be used to synthesize intermediate of Desogestrel and its preparation method and application
CN109293724A (en) A kind of preparation method of triamcinolone
CN108250008A (en) 3,3,3`, 3`- tetramethyl -1,1`- spiro indan -6,6`- diol, derivatives chiral separation methods
CN104356187B (en) Method for recycling hydrocortisone in hydrocortisone butyrate mother liquor

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20160518

RJ01 Rejection of invention patent application after publication